Qualcomm Issues Statement on Broadcom Director Nominees
Get Alerts QCOM Hot Sheet
Overall Analyst Rating:
NEUTRAL ( Down)
Dividend Yield: 2.1%
EPS Growth %: +7.9%
Join SI Premium – FREE
SAN DIEGO, Dec. 4, 2017 /PRNewswire/ -- Qualcomm Incorporated (NASDAQ: QCOM) ("Qualcomm" or the "Company") today confirmed receipt of Broadcom Limited's (NASDAQ: AVGO) nomination of a slate of candidates to replace Qualcomm's existing Board of Directors at the Company's 2018 Annual Meeting of Stockholders.
The full release is available on the Qualcomm News Center website at (https://www.qualcomm.com/news/releases/2017/12/04/qualcomm-issues-statement-broadcom-director-nominees)
About Qualcomm Qualcomm's technologies powered the smartphone revolution and connected billions of people. We pioneered 3G and 4G – and now we are leading the way to 5G and a new era of intelligent, connected devices. Our products are revolutionizing industries, including automotive, computing, IoT, healthcare and data center, and are allowing millions of devices to connect with each other in ways never before imagined. Qualcomm Incorporated includes our licensing business, QTL, and the vast majority of our patent portfolio. Qualcomm Technologies, Inc., a subsidiary of Qualcomm Incorporated, operates, along with its subsidiaries, all of our engineering, research and development functions, and all of our products and services businesses, including, our QCT semiconductor business. For more information, visit Qualcomm's website, OnQ blog, Twitter and Facebook pages.
Qualcomm Contacts:Pete Lancia, Corporate CommunicationsPhone: 1-858-845-5959Email: [email protected]
John Sinnott, Investor RelationsPhone: 1-858-658-4813Email: [email protected]
View original content:http://www.prnewswire.com/news-releases/qualcomm-issues-statement-on-broadcom-director-nominees-300565835.html
SOURCE Qualcomm Incorporated
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bread Financial Holdings, Inc. (BFH) Provides Performance Update for March 2024
- New Clinical Study Identifies Personalized Treatment Options for Metastatic Non-Small Cell Lung Cancer With Plasma Proteome Testing
- 4WEB Medical Announces Regulatory Clearance of its Anterior Spine Truss System with Anchor Fixation
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!